籌劃中
Pathology Managed Service – Preliminary Market Engagement
Gloucestershire Hospitals NHS Foundation Trust已就「Pathology Managed Service – Preliminary Market Engagement」發布此招標,現已不再接受新的投標。
此招標已不再接受新的投標。 類似的進行中招標
用淺白語言說明,這項招標是什麼?
此公告尚未翻譯,以原文語言顯示。
同類招標的過往批出紀錄說明了甚麼?
- 同類招標平均每項約有 1.5 份投標(10 項批出紀錄載有數目)。
- 半數同類合約的批出金額介乎 £49,686 至 £382,000,中位數為 £136,000。
- CONSTELLIA LIMITED 在過去三年從此採購方取得 3 份同類合約。
根據過去 36 個月 142 項批出紀錄:相同工種、相同地區。可信程度:高。以上只反映過往情況,並非預測結果。 批出合約資料
誰贏得這項招標,金額是多少?
此招標尚未公布批出結果。
公告全文
原文(English)
Pathology Managed Service – Preliminary Market Engagement
Gloucestershire Hospitals NHS Foundation Trust (“the Authority”) is undertaking preliminary market engagement ahead of a competitive procurement for a Pathology Managed Service. The intended contract will provide, as a managed service, the laboratory equipment (analytical platforms, automation, point-of-care devices and associated instrumentation), reagents, consumables, maintenance, software/middleware, training and lifecycle replacement required to deliver the Authority’s pathology service.
The service is expected to be structured in two phases: Phase 1 covering the Authority’s existing laboratories at Gloucestershire Royal Hospital and Cheltenham General Hospital, and Phase 2 following consolidation into a new-build pathology hub. The Authority’s working direction is a new-build hub with the location not yet determined; two options remain under consideration, each with implications for the service model that suppliers should allow for:
A hub on the Gloucester (hospital) site would require continued urgent haematology and clinical chemistry provision at Cheltenham General.
An off-site hub would require acute (hot lab) provision and resilience at both Gloucestershire Royal and Cheltenham General. Transfusion provision should not be assumed at all three locations (remote issue, transport, storage, space and staffing remain dependencies); for microbiology, an off-site hub may require on-site blood-culture loading at the acute sites and further review of patient-facing sample collection and cryo/storage services. For cellular pathology, reliable frozen-section transport between sites would be essential.
The disciplines in scope are Blood Sciences (clinical biochemistry, haematology, coagulation, immunology, transfusion-related equipment where included), Infection Sciences (microbiology, virology/molecular) and Cellular Pathology, together with enabling works to prepare laboratory space for installation. The Authority anticipates a lead provider for Blood Sciences with further lots or sub-lots for the other disciplines; the lot structure is a matter on which market feedback is sought.
The Authority is seeking supplier feedback on the draft service specification, draft key performance indicators, the proposed lot structure and phasing, the commercial and pricing model, the evaluation approach and the proposed timetable, in order to finalise its procurement strategy and tender documents. Participation is open to all interested suppliers including SMEs, specialist providers and potential sub-contractors or consortium members.
以電郵接收這些招標
每天一封電郵,列出你所選行業及地區的新招標。無需帳戶或密碼。
快速解答
這項招標何時截止?
公告沒有列明截止日期。請查閱採購方的入口網站。
這份合約價值多少?
採購方估計價值為£180,000,000。
採購方是誰?
採購方是Gloucestershire Hospitals NHS Foundation Trust。
同類招標通常有多少企業投標?
同類招標平均每項約有 1.5 份投標(10 項批出紀錄載有數目)。 根據過去 36 個月 142 項批出紀錄:相同工種、相同地區。可信程度:高。以上只反映過往情況,並非預測結果。